Canaccord analyst William Plovanic raised the firm’s price target on SI-Bone (SIBN) to $27 from $26 and keeps a Buy rating on the shares. The firm updated its model to largely reflect their new 2027 estimates, with some updates to 2026 estimates as well.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SIBN:
- SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham
- SI-Bone price target raised to $23 from $20 at Morgan Stanley
- SI-BONE, Inc. Reports Strong Q3 2025 Earnings
- SI-Bone’s Strong Q3 Performance and Strategic Initiatives Signal Promising Growth and Compelling Buy Opportunity
- SI-Bone’s Strong Financial Performance and Growth Prospects Justify Buy Rating